Thrombocythemia相关论文
原发性血小板增多症是一种少见的慢性骨髓增殖性疾病，以血小板持续增高为特征，临床上主要表现为出血和血栓。此病在民航飞行员中的研......
目的:探讨n JAK2 V617F基因突变呈阴性原发性血小板增多症(ET)患儿的临床、实验室检查及基因突变特征。n 方法:选择2017......
目的:探讨仅以血小板增多为首发而没有典型慢性粒细胞白血病(CML)表现的5例患者的临床诊断及治疗效果.方法:回顾性分析5例仅以血小......
目的 观察伊马替尼治疗bcr-abl融合基因阳性原发性血小板增多症(ET)的疗效.方法 以伊马替尼(200～400mg/d)治疗1例对羟基脲(HU)产生......
Spurious serum hyperkalemia occurs in the presence of extremely high platelet or white cell counts.Unlike other more com......
目的探讨以血小板显著增多为首发表现的慢性粒细胞白血病（CML）的临床及分子生物学特点。方法应用细胞涂片观察形态学;RT-PCR检测bcr/......
BACKGROUND Gastroesophageal varices are a rare complication of essential thrombocythemia(ET).ET is a chronic myeloprolif......
目的：探讨原发性血小板增多症患者血栓及出血的发生率，各种药物的疗效及患者的预后。方法：对我院１９８０年１月－１９９８年１２月间诊治的ＥＴ患者进行回顾性分析......
目的：探讨中国年轻原发性血小板增多症（ET）患者的临床特点及长期转归,建立年轻ET患者特异的血栓预测模型,为预后判断及治疗提供依据。......
Myeloproliferative and thrombotic burden and treatment outcome of thrombocythemia and polycythemia p
Prospective studies indicate that the risk of microvascular and major thrombosis in untreated thrombocythemia in various......
目的：探讨无原发疾病创伤性脾破裂行脾切除术后血小板计数的变化及处理措施。方法：无原发疾病创伤性脾破裂116例。脾切除术前查血小......
目的探讨有出血倾向的妊娠晚期并发原发性血小板增多症病人诊治方法。方法回顾性分析1例妊娠晚期并发原发性血小板增多症并有出血......
Leukocytosis at Diagnosis in Patients with Essential Thrombocythemia Is a Risk Factor for Transforma
Myelofibrosis (MF) represents the major long-term complication of essential thrombocythemia (ET). There is evidence that......
目的观察羟基脲联合血小板去除术治疗老年原发性血小板增多症（ET）的临床疗效。方法根据有无临床症状，将28例老年ET患者分为有临床症状......
We report a case of essential thrombocythemia(ET) in a 30-year-old female who exhibited inferior wall ST-elevation acute......
Risk of second primary malignancies in a population-based study of adult patients with essential thr
AIM:To determine the risk of second primary malignancy(SPM)and survival of patients with essential thrombocythemia(ET).M......
Pseudohyperkalemia caused by essential thrombocythemia in a patient with chronic renal failure: A ca
BACKGROUND Hyperkalemia is one of the most common complications of chronic renal failure.Pseudohyperkalemia is caused by......
PVSG and WHO vs European Clinical,Molecular and Pathological Criteria for prefibrotic myeloprolifera
The Polycythemia Vera Study Group(PVSG),World Health Organization(WHO)and European Clinical,Molecular and Pathological(E......
European vs 2015-World Health Organization clinical molecular and pathological classification of mye
The BCR/ABL fusion gene or the Ph1-chromosome in the t(9;22)(q34;q11)exerts a high tyrokinase acticity,which is the caus......
